The Venezuelan Medical Academy warns of possible risks of Cuban evacuation tests against COVID-19

La Venezuela Medical Academy demonstrates its preoccupation with dictator Nicolás Maduro of the 60,000 dose of Cuba for a phase of clinical trials against coronavirus, that the proofs of candidates for vacancies in which the participating countries guarantee the respect of ethical and scientific criteria, alerted in a communication.

In April, the experimental tests of Soberana 02 and Abdala will be launched, the candidates for vacancies produced in Cuba. “The vacancies are products with security and efficiencies and have been demonstrated in phase 3 trials generally conducted on human volunteers in the country of origin of the vacancy. Candidates for vacancies will determine their experimental products with safety and efficacy, ”said the organization in a statement.

In a televised speech, the dictator chavistas announced that 30,000 units of each of these vacancies will travel to the country to be applied during the third and final phase of the trial, as well as with the Russian Sputnik V, who traveled to Venezuela as the first country in the United States to study.

Candidates for the Soberana 02 and Abdala vacancies are experimental products that have just started evaluating in Cuba. The little that is known is about periodicals from the island. Dichos products, although based on the same concept that has been used in other vacancies issued against the COVID (induction of immunity against the protein of the virus surface), use ancient methodologies that have not been tested in the case of the COVID- 19 ″, Advirtió la Academia de Medicina de Venezuela.

The experimental tests of Soberana 02 and Abdala begin to test in March in Cuba in a population of about 44,000 volunteers each product. Phase 3 trials will last until mid-June in the Caribbean.

This type of trial phase 3 requires that the meeting of the volunteers receive the vaccine and the other meeting receive a placebo injection, in order to be able to conclude that the vaccine is safe and effective. Although many products are listed in the data base of the World Health Organization, the information is incomplete or inaccessible. For example, we do not know the results of phase 1-2 that our products and products have the ability to induce in humans a level and quality of antibodies that can confer protection against the virus ”, declaration of the organization.

In a communiqué previo, the Academy of Medicine recalls that it is “special import” to insure “that citizenship does not confuse access to a safety and efficacy reconnaissance vehicle, to participate as a volunteer in an experimental phase of a vacancy candidate ”.

“Parallel activity activities can create confusion and reduce the effectiveness of a National Vacation Plan against covid-19”, subrayan.

The Academy says that the dictatorial chavista “will participate in trials of experimental products with unknown characteristics”, must prove the reconciliation of vacancies for its safety and efficacy.

With EFE information

SEGUIR LEYENDO: